Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
13 April 2017Website:
http://www.fortebiorx.comNext earnings report:
13 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 30 Oct 2024 20:08:08 GMTDividend
Analysts recommendations
Institutional Ownership
FBRX Latest News
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What type of business is Forte Biosciences?
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
What sector is Forte Biosciences in?
Forte Biosciences is in the Healthcare sector
What industry is Forte Biosciences in?
Forte Biosciences is in the Biotechnology industry
What country is Forte Biosciences from?
Forte Biosciences is headquartered in United States
When did Forte Biosciences go public?
Forte Biosciences initial public offering (IPO) was on 13 April 2017
What is Forte Biosciences website?
https://www.fortebiorx.com
Is Forte Biosciences in the S&P 500?
No, Forte Biosciences is not included in the S&P 500 index
Is Forte Biosciences in the NASDAQ 100?
No, Forte Biosciences is not included in the NASDAQ 100 index
Is Forte Biosciences in the Dow Jones?
No, Forte Biosciences is not included in the Dow Jones index
When was Forte Biosciences the previous earnings report?
No data
When does Forte Biosciences earnings report?
The next expected earnings date for Forte Biosciences is 13 November 2024